Key result
Chronic kidney disease is a major global public health issue with an estimated worldwide prevalence of 8-16%, requiring inclusion in national non-communicable disease programs.
Why the study?
Chronic kidney disease is an increasing public health issue with high complication rates, yet awareness remains low in many communities and among many physicians.
Answers are grounded in this paper and cite their sources.
Review demonstrates the escalating worldwide burden of chronic kidney disease, highlighting the urgent need for global prevention strategies.
Chronic kidney disease is defined as a reduced glomerular filtration rate, increased urinary albumin excretion, or both, and is an increasing public health issue. Prevalence is estimated to be 8-16% worldwide. Complications include increased all-cause and cardiovascular mortality, kidney-disease progression, acute kidney injury, cognitive decline, anaemia, mineral and bone disorders, and fractures. Worldwide, diabetes mellitus is the most common cause of chronic kidney disease, but in some regions other causes, such as herbal and environmental toxins, are more common. The poorest populations are at the highest risk. Screening and intervention can prevent chronic kidney disease, and where management strategies have been implemented the incidence of end-stage kidney disease has been reduced. Awareness of the disorder, however, remains low in many communities and among many physicians. Strategies to reduce burden and costs related to chronic kidney disease need to be included in national programmes for non-communicable diseases.
No takes yet. Share an insight, caveat, or question.
Jha et al. (2013) conducted a review in Chronic kidney disease. Chronic kidney disease is a major global public health issue with an estimated worldwide prevalence of 8-16%, requiring inclusion in national non-communicable disease programs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: